Notes - Segment Information, Etc.

ASKA Pharmaceutical Holdings CO., Ltd. - Filing #7256194

Concept 2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2024-04-01 to
2025-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
2023-04-01 to
2024-03-31
Notes - Segment information, etc.
Segment information
Disclosure of sales and profit (loss) for each reportable segment
Sales
Revenues from external customers
64,139,000,000 JPY
237,000,000 JPY
JPY
56,655,000,000 JPY
7,246,000,000 JPY
64,139,000,000 JPY
JPY
56,016,000,000 JPY
62,843,000,000 JPY
162,000,000 JPY
JPY
62,843,000,000 JPY
6,664,000,000 JPY
Transactions with other segments
JPY
88,000,000 JPY
-88,000,000 JPY
JPY
JPY
88,000,000 JPY
JPY
JPY
JPY
64,000,000 JPY
-64,000,000 JPY
64,000,000 JPY
JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.